Glimepiride
Beta Cell - Protocol 2
Unknown small_molecule active
Quick answer
Glimepiride for Type 2 Diabetes is a Unknown program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Type 2 Diabetes
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active